Myhibbin 200 MG in 1 mL Oral Suspension
- RxCUI
- 2684851
- RxNorm name
- Myhibbin 200 MG in 1 mL Oral Suspension
- Display name
- Myhibbin 200 MG in 1 mL Oral Suspension
- Full name
- Myhibbin 200 MG in 1 mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MYHIBBIN | MYCOPHENOLATE MOFETIL | Azurity Pharmaceuticals, Inc. | d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 2684851 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9 | Myhibbin 200 MG in 1 mL Oral Suspension [PSN] · mycophenolate mofetil 200 MG/ML Oral Suspension [Myhibbin] [SBD] · Myhibbin 200 MG per 1 ML Oral Suspension [SY] · Myhibbin 200 MG/ML Oral Suspension [SY] | 4 | 5 | These highlights do not include all the information needed to use MYHIBBIN safely and effectively. See full prescribing information for MYHIBBIN. MYHIBBIN ® (mycophenolate mofetil oral suspension) Initial U.S. Approval: 1995 | 20260401 |